Health Care • Hospital/Nursing Management
$176.61 ▲ +4.43
(+2.57%)
MKT CAP: $10.41B • VOL: 1.01M
52W L $140 52W H $246
UHS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.36B | $15.83B | $14.28B |
| YoY Revenue Growth % | +9.7% | +10.8% | — |
| Gross Profit | $7.64B | $6.96B | $6.28B |
| Gross Margin % | 44.0% | 44.0% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.99B | $1.68B | $1.18B |
| Operating Margin % | 11.5% | 10.6% | 8.2% |
| Net Income (GAAP) | $1.49B | $1.14B | $717.8M |
| EBITDA (Normalized) | $2.81B | $2.44B | $1.69B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.86B | $2.07B | $1.27B |
| Capital Expenditures (CapEx) | $1.02B | $943.8M | $642.7M |
| Free Cash Flow (FCF) | $849.2M | $1.12B | $625.1M |
| FCF Margin % | 4.9% | 7.1% | 4.4% |
| Return on Invested Capital (ROIC %) | 14.1% | 12.1% | 9.0% |
| Cash & Short-Term Equivalents | $137.8M | $126.0M | $1.89B |
| Total Debt (Short + Long Term) | $4.00B | $4.46B | $4.01B |
| Total Stockholders' Equity | $7.28B | $6.67B | $8.23B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR UHS.